Pettit D - Search Results

1

Hydrophobic interaction chromatography of soluble interleukin I receptor type II to reveal chemical degradations resulting in loss of potency.

Zhang Y, Martinez T, Woodruff B, Goetze A, Bailey R, Pettit D, Balland A. Zhang Y, et al. Among authors: pettit d. Anal Chem. 2008 Sep 15;80(18):7022-8. doi: 10.1021/ac800928z. Epub 2008 Aug 16. Anal Chem. 2008. PMID: 18707131

2

Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry.

Yan B, Valliere-Douglass J, Brady L, Steen S, Han M, Pace D, Elliott S, Yates Z, Han Y, Balland A, Wang W, Pettit D. Yan B, et al. Among authors: pettit d. J Chromatogr A. 2007 Sep 14;1164(1-2):153-61. doi: 10.1016/j.chroma.2007.06.063. Epub 2007 Jul 5. J Chromatogr A. 2007. PMID: 17640657

3

Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling.

Pettit DK, Bonnert TP, Eisenman J, Srinivasan S, Paxton R, Beers C, Lynch D, Miller B, Yost J, Grabstein KH, Gombotz WR. Pettit DK, et al. J Biol Chem. 1997 Jan 24;272(4):2312-8. doi: 10.1074/jbc.272.4.2312. J Biol Chem. 1997. PMID: 8999939 Free article.

4

Biodegradable polymers for protein and peptide drug delivery.

Gombotz WR, Pettit DK. Gombotz WR, et al. Among authors: pettit dk. Bioconjug Chem. 1995 Jul-Aug;6(4):332-51. doi: 10.1021/bc00034a002. Bioconjug Chem. 1995. PMID: 7578352 Review.

5

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

Pettit DK, Rogers RS, Arthur K, Brodsky Y, Clark RH, Crowell C, Ennis J, Gillespie A, Gillespie R, Livingston B, Nalbandian E, Pace D, Smidt P, Pauly M, Timmons K, Trentalange M, Whaley KJ, Zeitlin L, Thomas JN. Pettit DK, et al. MAbs. 2016;8(2):347-57. doi: 10.1080/19420862.2015.1127492. MAbs. 2016. PMID: 26761424 Free PMC article.

6

The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals.

Pettit DK, Gombotz WR. Pettit DK, et al. Trends Biotechnol. 1998 Aug;16(8):343-9. doi: 10.1016/s0167-7799(98)01186-x. Trends Biotechnol. 1998. PMID: 9720323 Review.

7

Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.

Pettit DK, Lawter JR, Huang WJ, Pankey SC, Nightlinger NS, Lynch DH, Schuh JA, Morrissey PJ, Gombotz WR. Pettit DK, et al. Pharm Res. 1997 Oct;14(10):1422-30. doi: 10.1023/a:1012176823155. Pharm Res. 1997. PMID: 9358556

8

Release of PEGylated granulocyte-macrophage colony-stimulating factor from chitosan/glycerol films.

Brown CD, Kreilgaard L, Nakakura M, Caram-Lelham N, Pettit DK, Gombotz WR, Hoffman AS. Brown CD, et al. Among authors: pettit dk. J Control Release. 2001 May 14;72(1-3):35-46. doi: 10.1016/s0168-3659(01)00260-7. J Control Release. 2001. PMID: 11389983

9

Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.

Daro E, Pulendran B, Brasel K, Teepe M, Pettit D, Lynch DH, Vremec D, Robb L, Shortman K, McKenna HJ, Maliszewski CR, Maraskovsky E. Daro E, et al. Among authors: pettit d. J Immunol. 2000 Jul 1;165(1):49-58. doi: 10.4049/jimmunol.165.1.49. J Immunol. 2000. PMID: 10861034

10

Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubility.

Tan PH, Chu V, Stray JE, Hamlin DK, Pettit D, Wilbur DS, Vessella RL, Stayton PS. Tan PH, et al. Among authors: pettit d. Immunotechnology. 1998 Oct;4(2):107-14. doi: 10.1016/s1380-2933(98)00011-6. Immunotechnology. 1998. PMID: 9853952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters